Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126430032 | 12643003 | 2 | F | 20160823 | 20160811 | 20160901 | EXP | CA-AMGEN-CANSP2016102440 | AMGEN | 55.00 | YR | A | F | Y | 0.00000 | 20160831 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126430032 | 12643003 | 1 | PS | ENBREL | ETANERCEPT | 1 | Unknown | 50 MG, UNK | U | 103795 | 50 | MG | UNKNOWN FORMULATION | ||||||
| 126430032 | 12643003 | 2 | SS | METHOTREXATE. | METHOTREXATE | 1 | Oral | 20 MG, QWK | 0 | 20 | MG | /wk | |||||||
| 126430032 | 12643003 | 3 | SS | METHOTREXATE. | METHOTREXATE | 1 | Oral | 15 MG, QWK | 0 | 15 | MG | /wk | |||||||
| 126430032 | 12643003 | 4 | SS | HUMIRA | ADALIMUMAB | 1 | Oral | 40 MG, UNK | 0 | 40 | MG | INJECTION | |||||||
| 126430032 | 12643003 | 5 | SS | LEFLUNOMIDE. | LEFLUNOMIDE | 1 | Oral | 20 MG, QD | 0 | 20 | MG | QD | |||||||
| 126430032 | 12643003 | 6 | SS | LEFLUNOMIDE. | LEFLUNOMIDE | 1 | Oral | 10 MG, QD | 0 | 10 | MG | QD | |||||||
| 126430032 | 12643003 | 7 | C | CELEBREX | CELECOXIB | 1 | Oral | UNK UNK, BID | 0 | BID | |||||||||
| 126430032 | 12643003 | 8 | C | PREDNISONE. | PREDNISONE | 1 | UNK UNK, 2 TIMES/WK | 0 | BIW | ||||||||||
| 126430032 | 12643003 | 9 | C | TYLENOL | ACETAMINOPHEN | 1 | UNK | 0 | |||||||||||
| 126430032 | 12643003 | 10 | C | AMITRIPTYLINE | AMITRIPTYLINE | 1 | UNK | 0 | |||||||||||
| 126430032 | 12643003 | 11 | C | LEUCOVORIN. | LEUCOVORIN | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126430032 | 12643003 | 1 | Rheumatoid arthritis |
| 126430032 | 12643003 | 2 | Rheumatoid arthritis |
| 126430032 | 12643003 | 4 | Rheumatoid arthritis |
| 126430032 | 12643003 | 5 | Product used for unknown indication |
| 126430032 | 12643003 | 7 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126430032 | 12643003 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126430032 | 12643003 | Alopecia | |
| 126430032 | 12643003 | Drug ineffective | |
| 126430032 | 12643003 | Gait disturbance | |
| 126430032 | 12643003 | Rheumatoid arthritis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126430032 | 12643003 | 1 | 201404 | 201504 | 0 | |
| 126430032 | 12643003 | 2 | 201308 | 201605 | 0 | |
| 126430032 | 12643003 | 4 | 201601 | 201607 | 0 | |
| 126430032 | 12643003 | 5 | 201210 | 201605 | 0 |